Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Brent Flickinger (NPI 1902914872)

Field	Value
Entity Type	Individual
Organization	Brent Flickinger
Address	700 S Enota Dr Ne
City	Gainesville
State	GA
ZIP	30501
Taxonomy	Rheumatology Physician
NPI Enumerated	August 29, 2006

Payer Source	Total Paid
Medicare	$2.3M
Medicaid	$0

Key Findings

This provider’s billing is concentrated almost entirely in Medicare: lifetime Medicare revenue is $2.3M and there is no Medicaid billing on file, so the practice operates effectively as a single-payer (Medicare) outpatient rheumatology site. The precomputed concentration is high — the top 3 Medicare codes account for 63.8% of the provider’s total Medicare revenue — which implies revenue drivers are tightly focused on a few services.

The revenue mix is dominated by biologic drug administration: J0129 accounts for $782K (33.6% of Medicare revenue), J9312 accounts for $377.1K (16.2%), and J3262 accounts for $323.8K (13.9%). Together these drug/infusion codes drive the majority of income and are consistent with a rheumatology practice that delivers in‑office biologic infusions or supervised injections rather than relying on E/M visits for most revenue.

Operationally, the practice supports infusion and administration workflows: infusion/chemotherapy administration codes 96413 ($25.1K), 96365 ($21.2K), and the infusion add‑on 96415 ($5.1K) are present on the profile, indicating regular in‑office intravenous/subcutaneous administration and associated chair time. These ancillary administration codes complement the high-dollar biologic J‑codes and suggest on-site nursing and infusion resources to manage biologic therapies.

Clinical support services are present but modest relative to drug revenue: routine lab and diagnostic codes such as 80053 ($8.8K), 86140 ($3.4K), 86160 ($2.6K), 82306 ($2.2K), and 36415 ($6.2K) appear in the top 25 but together represent small shares of total Medicare revenue. This pattern — high drug/administration revenue with smaller ancillary testing and procedure revenue — is typical for subspecialty clinics that center on ongoing biologic treatment and disease monitoring.

Competitive standing on the top biologics shows above‑median national placement but is described in the source labels as typical: J0129 ranks #98 of 1221 (92th percentile; typical, unremarkable volume for this code), J9312 ranks #42 of 317 (87th percentile; typical, unremarkable volume for this code), and J3262 ranks #153 of 618 (75th percentile; typical, unremarkable volume for this code). In plain terms, the provider treats biologic therapies at volumes above the national median for these agents but the supplied descriptors characterize that activity as within expected norms rather than an extreme outlier.

Service mix shows reimbursement centered on drugs rather than office E/M revenue: the E/M code 99214 contributes $63K (2.7% of Medicare revenue) while the top J‑code J0129 alone is $782K (33.6%). This indicates the practice’s financial model is driven by drug administration reimbursements rather than high volumes of higher‑level evaluation and management visits.

One specific utilization signal stands out statistically: 99214 is labeled in the source as "notably above typical national volume for this code" (rank #25597 of 479517; 95th percentile), which suggests the provider delivers a relatively high number of moderate-complexity established-patient visits compared with national peers. Combined with the biologic administration profile, this may reflect ongoing chronic care management visits tied to biologic therapy oversight.

The provider’s tenure is long and stable: NPI enumerated on 2006-08-29 (~20 years ago), which supports interpretation of these billing patterns as established practice behavior rather than a short‑term fluctuation. Given the absence of Medicaid billing, the practice’s patient panel and revenue exposure are skewed toward Medicare beneficiaries and the clinical workflows and pricing associated with biologic infusions in that population.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

45 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	23,000	$30	$782K
J9312	Injection, rituximab, 10 mg	5,990	$60	$377.1K
J3262	Injection, tocilizumab, 1 mg	64,760	$10	$323.8K
J1602	Injection, golimumab, 1 mg, for intravenous use	25,570	$10	$281.3K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	55,600	$1	$222.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	710	$90	$63K
J3111	Injection, romosozumab-aqqg, 1 mg	6,510	$10	$52.1K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1,910	$30	$47.8K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	1,550	$30	$45K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	270	$90	$25.1K

Showing 1–10 of 45

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 45 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

Brent Flickinger — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

45 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	4	30	9,660	$30	$403.6K
J9312	4	10	4,620	$60	$307.4K
J1602	8	30	17,200	$10	$240.1K
J3262	3	10	45,840	$1	$233.4K
J0717	4	20	38,000	$1	$199.3K
J3111	18	20	12,810	$10	$172.9K
J1745	16	30	2,160	$30	$96.6K
J0897	240	290	2,460	$20	$90.2K
Q5104	4	10	2,320	$30	$71.3K
96413	50	160	170	$90	$20.3K

Showing 1–10 of 45

Related Providers

Other providers that share a Tax Identification Number (TIN) with Brent Flickinger, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
William Chafin	GA	Rheumatology Physician	$3.3M	$0
Taylor Mader	SC	Rheumatology Physician	$3.1M	$0
Dean Stephens	GA	Rheumatology Physician	$2.7M	$0
Charles Degenhardt	GA	Rheumatology Physician	$2.4M	$0
Paul Sutej	GA	Rheumatology Physician	$2.4M	$0
Durga Adhikari	SC	Rheumatology Physician	$2.4M	$0
Marta Bognar	GA	Rheumatology Physician	$2.3M	$0
Kathleen Flint	SC	Rheumatology Physician	$2.3M	$0
Colin Edgerton	SC	Rheumatology Physician	$1.9M	$0
John Brittis	SC	Rheumatology Physician	$1.9M	$0

Nearby Providers

Other providers in the same ZIP code as Brent Flickinger, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Northeast Georgia Medical Center, Inc.	GA	General Acute Care Hospital	$0	$112.9M
Georgia Emergency Department Services, P.C.	GA	Emergency Medicine Physician	$0	$17.9M
S.y.a.h.	GA	Urgent Care Clinic/Center	$0	$6.5M
Pediatric Associates LLP	GA	Pediatrics Physician	$0	$5M
Gainesville Radiology Group, PC	GA	Diagnostic Radiology Physician	$0	$2M
Hall County Georgia	GA	Land Ambulance	$1.6M	$0
Northeast Georgia Physicians Group Urgent Care LLC	GA	Family Medicine Physician	$0	$1.6M
Timothy Carey	GA	Medical Oncology Physician	$1.5M	$0
Gainesville Surg Ctr LP	GA	Ambulatory Surgical Clinic/Center	$1.4M	$0
Gainesville Eye Center, LLC	GA	Ambulatory Surgical Clinic/Center	$1.4M	$0

Brent Flickinger — Billing Profile & Reimbursement Data

Sign up for Brent Flickinger — Billing Profile & Reimbursement Data policy alerts

Brent Flickinger — Billing Profile & Reimbursement Data

Sign up for Brent Flickinger — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References